In short
- The management metric increased 27.8% year on year to ¥1,576 million, marking its ninth consecutive year of growth.
- Ordinary profit was ¥207 million, resulting in a profit for the second consecutive fiscal year, due to ¥533 million in subsidy income and other factors.
- For the fiscal year ending September 2027, the company plans for a management metric of ¥1,853 million, while forecasting an operating loss of ¥350 million due to higher depreciation and amortization expense and other factors.
What they reported
this period against the same period a year earlier, and where they now expect the year to endSales
| Period | ¥bn |
|---|---|
| FY24/9 Q1 | 0.0 |
| FY24/9 Q2 | 0.1 |
| FY24/9 Q3 | 0.0 |
| FY24/9 Q4 | 0.8 |
| FY25/9 Q1 | 0.0 |
| FY25/9 Q2 | 0.2 |
| FY25/9 Q3 | 0.1 |
| FY25/9 Q4 | 0.8 |
| FY26/9 Q1 | 0.1 |
| FY26/9 Q2 | 0.2 |
| FY26/9 Q3 | 0.0 |
Revenue declined year on year due to the reversal of license income recorded in the previous fiscal year and other factors.
前期は原価を伴わないライセンス収入226百万円(技術移転、技術使用許諾、ロイヤリティなど)を計上。その反動で売上総利益が減少。Revenue for the fiscal year ended September 2026 exceeded the earnings forecast by ¥7 million.
売上高は1,042百万円(業績予想比+0.7%)、売上総利益は438百万円(同+11百万円)。Operating profit
| Period | ¥m |
|---|---|
| FY24/9 Q1 | -118.0 |
| FY24/9 Q2 | -107.0 |
| FY24/9 Q3 | -139.0 |
| FY24/9 Q4 | 216.0 |
| FY25/9 Q1 | -121.0 |
| FY25/9 Q2 | -12.0 |
| FY25/9 Q3 | -109.0 |
| FY25/9 Q4 | 238.0 |
| FY26/9 Q1 | -125.0 |
| FY26/9 Q2 | -61.0 |
| FY26/9 Q3 | -197.0 |
The operating loss was primarily due to the accounting treatment for the subsidy-funded project and higher depreciation and amortization expense for the new facilities.
営業利益が赤字になる、2つの理由The company forecasts an operating loss of ¥350 million for the fiscal year ending September 2027.
売上高は前期比+28.9%増、営業利益は△314百万円から△350百万円へ。理由は、補助事業の会計処理と先行投資の減価償却です。Ordinary profit
| Period | ¥m |
|---|---|
| FY24/9 Q1 | -118.0 |
| FY24/9 Q2 | -108.0 |
| FY24/9 Q3 | -139.0 |
| FY24/9 Q4 | 227.0 |
| FY25/9 Q1 | -121.0 |
| FY25/9 Q2 | -11.0 |
| FY25/9 Q3 | -110.0 |
| FY25/9 Q4 | 398.0 |
| FY26/9 Q1 | -124.0 |
| FY26/9 Q2 | -66.0 |
| FY26/9 Q3 | -196.0 |
Ordinary profit increased due to ¥533 million in subsidy income and other non-operating income.
営業外収益539百万円(うち補助金収入533百万円)を計上し、経常利益は2期連続の黒字。For the fiscal year ending September 2027, the company is targeting ordinary profit of ¥158 million and a third consecutive fiscal year of profitability.
経常利益は3期連続黒字を目指します。Net profit
| Period | ¥m |
|---|---|
| FY24/9 Q1 | -118.0 |
| FY24/9 Q2 | -108.0 |
| FY24/9 Q3 | -141.0 |
| FY24/9 Q4 | 234.0 |
| FY25/9 Q1 | -121.0 |
| FY25/9 Q2 | -13.0 |
| FY25/9 Q3 | -115.0 |
| FY25/9 Q4 | 376.0 |
| FY26/9 Q1 | -125.0 |
| FY26/9 Q2 | -67.0 |
| FY26/9 Q3 | -199.0 |
Net income was ¥177 million, an increase of ¥49 million from the previous fiscal year.
当期純利益は177百万円(同+49百万円)。Their own numbers
figures this company chose to report, a year ago against nowThe company's management metric, which combines revenue with subsidy and grant income, increased for the ninth consecutive fiscal year.
Three new items were added, bringing the pipeline to 19.
The addition of new feed- and agriculture-related products brought the total number of products to 11.
The company has achieved approximately threefold productivity through scale-up from 10 L to 3,000 L.
The low–high ranges are Komori's estimate, not figures the company gave.
Everything else in the deck
By business
New initiatives
- In collaboration with eREX Co.,Ltd., the company will advance the Golden Rice Circle Project in Vietnam to produce bioethanol and protein from surplus and underutilized rice.
- The company will develop fermentation and purification technologies for wood biomass-derived bioisobutanol by leveraging a support program of the Tokyo Metropolitan Government.
- The company is considering in-house production using commercial-scale facilities with a capacity of several tens of kL in Japan, alongside OEM production in Taiwan and elsewhere.
- The company is considering commercial production under contract manufacturing arrangements for agriculture-related products of domestic chemical manufacturers.
- The company will fully launch biofoundry services for private-sector customers from April 2027.
Investment in equipment
What decks usually leave out
COMPUTED = worked out by Komori from reported numbers; the rest are stated in this deckMargins and overheads
Overheads (selling and admin costs): ¥753.0m
Financial targets
| Period | % |
|---|---|
| FY23/9 | -5.2 |
| FY24/9 | -6.5 |
| FY25/9 | 6.2 |
| Period | % |
|---|---|
| FY22/9 | 65.5 |
| FY23/9 | 78.9 |
| FY24/9 | 72.2 |
| FY25/9 | 71.0 |
Yearly figures are computed by Komori from J-Quants results data (ROE = net profit ÷ average equity). The last point is this year's forecast or latest figure. Targets show only when this deck states them.
How they rate themselves against plan
The company evaluates the results for the fiscal year ended September 2026 as having exceeded the earnings forecast.
業績予想を上回って着地The line is the plan; a bar grows right by how far the result beat it and left by how far it missed, as a share of the plan.
Assumptions behind the forecast
Mid-term plan targets
Headcount
The company continues to recruit personnel toward its 2031 target.